PRTC — Puretech Health Balance Sheet
0.000.00%
- $459.37m
- $94.63m
- $4.83m
- 73
- 66
- 26
- 55
Annual balance sheet for Puretech Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 406 | 468 | 352 | 329 | 380 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.94 | 23.2 | 22.4 | 14.1 | 1.52 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 414 | 502 | 386 | 347 | 386 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 42.9 | 43.9 | 37.2 | 19.4 | 15.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 990 | 946 | 703 | 694 | 603 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 181 | 226 | 96.9 | 51.4 | 41.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 320 | 352 | 160 | 230 | 188 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 670 | 594 | 542 | 464 | 415 |
Total Liabilities & Shareholders' Equity | 990 | 946 | 703 | 694 | 603 |
Total Common Shares Outstanding |